The yearly cost of targeted cancer therapy may be around $80,000 to $100,000, but the exact cost depends on the type of disease, pathology, and medication regimen. Targeted cancer therapy is the use of molecularly targeted drugs that target specific molecules associated with tumors. The targets can be cell receptors, signaling pathways, etc. In terms of chemical properties, they can be divided into monoclonal antibodies and small molecule compounds. 1. Monoclonal antibodies: there is trastuzumab, roughly $7,600~8,600 per unit. Rituximab, a course of treatment is about 7,000~8,000 dollars. 2. Small molecule compounds: Tyrosine kinase inhibitors, such as imatinib, are common, and their cost is about 500~1,000 yuan, with a big price difference between different brands. It is recommended to choose the appropriate medication according to your own situation and under the guidance of your doctor.